(NASDAQ: TLPH) Talphera's forecast annual revenue growth rate of 120.8% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Talphera's revenue in 2024 is $651,000.On average, 1 Wall Street analysts forecast TLPH's revenue for 2025 to be $16,290,339, with the lowest TLPH revenue forecast at $16,290,339, and the highest TLPH revenue forecast at $16,290,339. On average, 1 Wall Street analysts forecast TLPH's revenue for 2026 to be $176,987,744, with the lowest TLPH revenue forecast at $176,987,744, and the highest TLPH revenue forecast at $176,987,744.
In 2027, TLPH is forecast to generate $482,261,907 in revenue, with the lowest revenue forecast at $482,261,907 and the highest revenue forecast at $482,261,907.